猪肝炎病毒细胞的受体1/肾损伤分子1/KIM1（HAVCR1
）ELISA试剂盒【Pig hepatitis A virus cellular receptor 1/KIM1(HAVCR1) ELISA Kit】- ￥3000 - 4200
- CUSABIO
- 0.04ng/mL
- Microbiology
- 武汉
- CSB-EL010144PI
- 2026年03月24日
企业认证
相关产品推荐更多 >
人小富脯氨酸蛋白2B（SPRR2B）ELISA试剂盒【Human Small proline-rich protein 2B(SPRR2B) ELISA Kit】
￥2500
猪免疫球蛋白M（IgM）ELISA试剂盒【Pig Immunoglobulin M,IgM ELISA Kit】
￥2500
小鼠克拉拉细胞蛋白（CC16）ELISA试剂盒【Mouse Clara cell protein,CC16 ELISA Kit】
￥2500人转录激活因子BRG1（SMARCA4）ELISA试剂盒【Human Transcription activator BRG1(SMARCA4) ELISA Kit】
￥2500人类胰岛素样生长因子结合蛋白6（IGFBP6）ELISA试剂盒【Human Insulin-like growth factor-binding protein 6(IGFBP6) ELISA Kit】
￥2500
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商：
武汉研升生物科技有限公司
- 检测范围：
0.04ng/mL
- 检测方法：
Sandwich
- 适应物种：
Sus scrofa (Pig)
- 样本：
serum, plasma, tissue homogenates
- 灵敏度：
Microbiology
- 规格：
96T/48T
| 规格： | 96T | 产品价格： | ￥4200.0 |
|---|---|---|---|
| 规格： | 48T | 产品价格： | ￥3000.0 |
| Product Name |
Pig hepatitis A virus cellular receptor 1/KIM1(HAVCR1) ELISA Kit |
| Chinese Name |
猪肝炎病毒细胞的受体1/肾损伤分子1/KIM1（HAVCR1）ELISA Kit |
| Code |
CSB-EL010144PI |
| Target Name |
hepatitis A virus cellular receptor 1/KIM1(HAVCR1) |
| Abbreviation |
HAVCR1 |
| Species |
Sus scrofa (Pig) |
| Sample Types |
serum, plasma, tissue homogenates |
| Detection Range |
0.18ng/mL-12ng/mL |
| Sensitivity |
0.04ng/mL |
| Assay Principle |
quantitative |
| Measurement |
Sandwich |
| Assay Time |
1-5h |
| Sample Volume |
50-100ul |
| Detection Wavelength |
450nm |
| Research Area |
Microbiology |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验The discovery of hepatitis B virus (HBV) four decades ago initiated the progressive increase in knowledge of an important hepatotropic infectious agent that culminated in the design of the first successful recombinant vaccine for a human
Investigation of the Hepatitis C Virus Replication Complex
Formation of a membrane-associated replication complex, composed of viral proteins, replicating RNA, altered cellular membranes, and other host factors, is a hallmark of all positive-strand RNA viruses. In the case of HCV, RNA replication
“Current regimens (interferon) to treat hepatitis D patients have only transient but no lasting effects (1 ).”
技术资料暂无技术资料 索取技术资料
